Hepion Pharmaceuticals, Inc. (HEPA) insider trading
Hepion Pharmaceuticals, Inc. insiders have made 1 open-market purchase worth $10k since Oct 2, 2026, by 1 insider. The latest: Danina Fisher (Director) bought $10k, filed Oct 2, 2026, scored 19 out of 100.
Follow HEPA, freeOpen the live feed
A free account gets an alert the minute a new buy or sale is filed.
Insider purchases
| Filed | Insider | Stake | Score | Bought | 1 week | 1 month |
|---|---|---|---|---|---|---|
| Oct 2 Form 4 (opens sec.gov) |
Danina FisherDirector · filed lateDirector · Filed late · Penny stock: hard to trade | New position | 19 | $10k 200,000 at $0.05 |
— | — |
Investors with more than 5% of HEPA (13D and 13G)
| Filed | Investor | Kind | Stake |
|---|---|---|---|
| Oct 27 13D | Gravitas Collective Corp. | Activist | 19.9% |
| Oct 21 13G/A | Kenneth Rickel | Passive | 7.2% |
A 13D is filed by an investor who may push for change; a 13G by a passive one.
Insiders who bought HEPA
- Danina Fisher Director
Questions
Are insiders buying HEPA stock?
Yes. In the last 90 days, 1 open-market purchase was filed, worth $10k.
Who bought HEPA stock most recently?
Danina Fisher, Director, bought 200,000 shares for $10k (Form 4 (opens sec.gov), filed Oct 2, 2026).
How does InsiderBeacon score an insider buy?
Out of 100, from who bought, how much their stake grew, the size of the trade, whether other insiders bought within ten days, where the price sat in its 52-week range, and whether it was a first or a routine buy. The score is fixed when the filing arrives. The formula and the research behind it.
Insiders are also buying, same industry
Data as of Oct 2, 2026, from SEC EDGAR Form 4 filings: open-market purchases (code P) of $25,000 or more, and open-market sales. Every row links to its filing. Scores summarise what a filing says (how the score works); outcomes are hypothetical, from the first close after the filing, and past results don't predict future ones. Disclaimer